Vaccinex, Inc.
Cash Flow Statement
| Line Item | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 | Mar 2023 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-5.7M | $-5.6M | $-3.9M | $-4.9M | $-7.1M | $-5.0M | $-4.8M | $-5.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $24.0K | $25.0K | $27.0K | $31.0K | $30.0K | $31.0K | $67.0K | $54.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | $96.0K | — | — | $129.0K | — | — |
| Net Cash from Operating Activities | $-3.2M | $-4.4M | $-4.6M | $-3.1M | $-5.5M | $-5.0M | $-4.1M | $-5.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $8.0K | $14.0K | $0 | $18.0K | $0 | $49.0K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $0 | — | — | $-49.0K | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $6.1M | — | — | $2.0M | — | — |
| Net Change in Cash | — | — | $1.4M | — | — | $-3.1M | — | — |
| Free Cash Flow | $-3.2M | $-4.4M | $-4.6M | $-3.1M | $-5.5M | $-5.1M | — | — |